Literature DB >> 9952397

Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease.

F R Fusco1, Q Chen, W J Lamoreaux, G Figueredo-Cardenas, Y Jiao, J A Coffman, D J Surmeier, M G Honig, L R Carlock, A Reiner.   

Abstract

Immunohistochemistry and single-cell RT-PCR were used to characterize the localization of huntingtin and/or its mRNA in the major types of striatal neurons and in corticostriatal projection neurons in rats. Single-label immunohistochemical studies revealed that striatum contains scattered large neurons rich in huntingtin and more numerous medium-sized neurons moderate in huntingtin. Double-label immunohistochemical studies showed that the large huntingtin-rich striatal neurons include nearly all cholinergic interneurons and some parvalbuminergic interneurons. Somatostatinergic striatal interneurons, which are medium in size, rarely contained huntingtin. Calbindin immunolabeling showed that the vast majority of the medium-sized striatal neurons that contain huntingtin are projection neurons, but only approximately 65% of calbindin-labeled projection neurons (localized to the matrix compartment of striatum) were labeled for huntingtin. Calbindin-containing projection neurons of the matrix compartment and calbindin-negative projection neurons of the striatal patch compartment contained huntingtin with comparable frequency. Single-cell RT-PCR confirmed that striatal cholinergic interneurons contain huntingtin, but only approximately 65% of projection neurons contained detectable huntingtin message. The finding that huntingtin is not consistently found in striatal projection neurons [which die in Huntington's disease (HD)] but is abundant in striatal cholinergic interneurons (which survive in Huntington's disease) suggests that the mutation in huntingtin that causes HD may not directly kill neurons. In contrast to the heterogeneous expression of huntingtin in the different striatal neuron types, we found all corticostriatal neurons to be rich in huntingtin protein and mRNA. One possibility raised by our findings is that the HD mutation may render corticostriatal neurons destructive rather than render striatal neurons vulnerable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952397      PMCID: PMC6786020     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  95 in total

1.  Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain.

Authors:  R S Petralia; R J Wenthold
Journal:  J Comp Neurol       Date:  1992-04-15       Impact factor: 3.215

2.  More false-positive problems.

Authors:  G D Cimino; K Metchette; S T Isaacs; Y S Zhu
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

3.  Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease--an in situ hybridization study.

Authors:  T Arzberger; K Krampfl; S Leimgruber; A Weindl
Journal:  J Neuropathol Exp Neurol       Date:  1997-04       Impact factor: 3.685

4.  Evidence for the preferential localization of glutamate receptor-1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum.

Authors:  Q Chen; L Veenman; K Knopp; Z Yan; L Medina; W J Song; D J Surmeier; A Reiner
Journal:  Neuroscience       Date:  1998-04       Impact factor: 3.590

5.  The identification of a functional nuclear localization signal in the Huntington disease protein.

Authors:  D A Bessert; K L Gutridge; J C Dunbar; L R Carlock
Journal:  Brain Res Mol Brain Res       Date:  1995-10

6.  Selective sparing of a class of striatal neurons in Huntington's disease.

Authors:  R J Ferrante; N W Kowall; M F Beal; E P Richardson; E D Bird; J B Martin
Journal:  Science       Date:  1985-11-01       Impact factor: 47.728

7.  Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons.

Authors:  S J Tallaksen-Greene; R L Albin
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

8.  Huntingtin localization in brains of normal and Huntington's disease patients.

Authors:  E Sapp; C Schwarz; K Chase; P G Bhide; A B Young; J Penney; J P Vonsattel; N Aronin; M DiFiglia
Journal:  Ann Neurol       Date:  1997-10       Impact factor: 10.422

9.  Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains.

Authors:  J C Adams
Journal:  J Histochem Cytochem       Date:  1992-10       Impact factor: 2.479

10.  Chronic intrastriatal quinolinic acid produces reversible changes in perikaryal calbindin and parvalbumin immunoreactivity.

Authors:  T J Bazzett; J B Becker; R C Falik; R L Albin
Journal:  Neuroscience       Date:  1994-06       Impact factor: 3.590

View more
  52 in total

Review 1.  The education of a brain transplant.

Authors:  J F Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 2.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

Review 3.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

4.  Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease.

Authors:  Dénes Zádori; Gábor Nyiri; András Szonyi; István Szatmári; Ferenc Fülöp; József Toldi; Tamás F Freund; László Vécsei; Péter Klivényi
Journal:  J Neural Transm (Vienna)       Date:  2010-12-31       Impact factor: 3.575

5.  Effects of mutant huntingtin on mGluR5-mediated dual signaling pathways: implications for therapeutic interventions.

Authors:  Shan-Shan Huang; Jun He; Dong-Ming Zhao; Xiao-Yuan Xu; Hui-Ping Tan; He Li
Journal:  Cell Mol Neurobiol       Date:  2010-07-20       Impact factor: 5.046

6.  Genetic interaction between expanded murine Hdh alleles and p53 reveal deleterious effects of p53 on Huntington's disease pathogenesis.

Authors:  Amy B Ryan; Scott O Zeitlin; Heidi Scrable
Journal:  Neurobiol Dis       Date:  2006-09-15       Impact factor: 5.996

7.  The Sensory Striatum Is Permanently Impaired by Transient Developmental Deprivation.

Authors:  Todd M Mowery; Kristina B Penikis; Stephen K Young; Christopher E Ferrer; Vibhakar C Kotak; Dan H Sanes
Journal:  Cell Rep       Date:  2017-06-20       Impact factor: 9.423

Review 8.  Brain networks in Huntington disease.

Authors:  David Eidelberg; D James Surmeier
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

9.  Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.

Authors:  Benjamin R Miller; Adam G Walker; Anand S Shah; Scott J Barton; George V Rebec
Journal:  J Neurophysiol       Date:  2008-07-30       Impact factor: 2.714

Review 10.  A role for autophagy in Huntington's disease.

Authors:  Katherine R Croce; Ai Yamamoto
Journal:  Neurobiol Dis       Date:  2018-08-24       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.